Good Health is Your Greatest Wealth……Virgil
A combination diet drug is expected to be approved by the FDA, and it's hailed as the next big thing in combating obesity, but the side-effects are serious. By Treacy Colbert Some hail the potential addition of a new drug to the weight–loss arsenal.
See all stories on this topic »
It's the newest weight–loss medication, Qnexa. This drug got the green light from a Food and Drug Administration (FDA) advisory panel on Feb. 22, a crucial step toward approval of the drug, which is expected in April. In 2010, an FDA advisory panel …
See all stories on this topic »
| The Food and Drug Administration has rejected three prescription diet pills in the last three years, raising questions of whether any weight loss drug can win approval in the US The agency has not approved a new prescription weight loss drug in 13 … See all stories on this topic » |
 USA TODAY |
AP – A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the U.S. market in more than a decade.
ContributorNetwork – A weight-loss pill from Vivus Inc. has become the first such drug recommended for approval by the FDA in more than 13 years. An advisory panel voted in favor of approving the pill, known as Qnexa, by a margin of 20-2 on Wednesday, according to MSNBC. The FDA has until April 17 to formally approve Qnexa for use in the United States.
| The experimental drug won the backing of health advisers, raising hopes for approval of the first prescription weight–loss pill in 13 years. By Anna Yukhananov, ReutersWed, Feb 22 2012 at 6:28 PM EST WEIGHT LOSS: Panelists said Vivus should conduct a … See all stories on this topic » |
 Mother Nature Network |
In a reversal, an FDA advisory committee backs the weight–loss drug Qnexa despite health risks after its maker, Vivus, promises strict oversight. By Shari Roan, Los Angeles Times A panel of medical experts voted overwhelmingly Wednesday to endorse the …
See all stories on this topic »
By AP By Matthew Perrone SILVER SPRING, Md. — A previously rejected weight loss pill won an overwhelming endorsement from public-health advisers Wednesday, Feb. 22, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity …
See all stories on this topic »
SILVER SPRING Md A panel of advisers to the Food and Drug Administration … adults doctors and public health officials say new weightloss therapies are …
www.msnbc.msn.com/id/46487890/…/health-diet_and_nutriti…
"Right now there aren't any good treatments out there besides dieting and bariatric surgery, clearly there's a huge gap." With US obesity rates nearing 35 percent among adults, doctors and public health officials say new weight–loss therapies are …
See all stories on this topic »
Reuters – An experimental obesity drug from Vivus Inc won a U.S. panel’s support on Wednesday, raising hopes regulators would approve a weight-loss pill for the first time in 13 years.
By Aaron Cooper, CNN (CNN) — Food and Drug Administration officials plan to investigate whether a form of caffeine sold in lipstick-shaped containers is safe for consumers. The inventor touts AeroShot as caffeine without the coffee, soda, …
See all stories on this topic »